(2026) -
Chronological (1861 items)
(All links open in new tab)
| Nov 12, 2026 |
First Phase Of Renewed Federal Hemp Product Ban Takes Effect As Industry Pushes Congress For Regulatory Alternative
As of Thursday, it is no longer federally legal to produce or sell hemp products that contain cannabinoids that can’t be naturally produced by the cannabis plant. A broader recriminalization of hemp THC products is currently scheduled to take effect next month, though industry advocates and a bipartisan group of lawmakers—in partnership with the Trump administration—have been pushing to enact legislation to enact regulations as an alternative to prohibition. |
|---|---|
| Nov 12, 2026 |
Eight in ten men report mental health improvements from medical cannabis
More than eight in ten men whose health conditions had affected their mental well-being reported an improvement after starting prescribed cannabis, a clinic-led survey has found. The survey, conducted by Releaf, gathered responses from 2,683 active patients, including 1,807 men. Almost half of the male respondents (49%) said their condition had affected their mental well-being before treatment. Of that group, 82% said it had since improved. |
| Nov 12, 2026 |
Dutch medical cannabis tender opens in December after Bedrocan bankruptcy
The Netherlands will publish a European tender for a new medicinal cannabis supplier in December, with deliveries planned from September 2027, Sophie Hermans, Minister of Health, Welfare and Sport, wrote to the Dutch House of Representatives on November 6. |
| Nov 12, 2026 |
Bedrocan Could Be Revived Under New Entity as Dutch Minister Tells Parliament UK Supply Is ‘Under Investigation’
Bedrocan’s recent collapse, which has endangered the supply of life-saving epilepsy medicine for dozens of patients across Europe, could soon be revived under a new entity. |
| Nov 12, 2026 |
Cannabis Telemedicine in Germany: Regulation, Market Entry, Advertising and Enforcement
Digital health is transforming Germany’s medical cannabis market. While technology makes treatment more accessible, the legal framework remains complex, particularly for online platforms, prescribing physicians and companies seeking to reach patients. |
| Nov 12, 2026 |
NUGL Reports Q3 2026 Results as KAYA Marks a Decade in Jamaica’s Regulated Cannabis Market
KINGSTON, Jamaica and LOS ANGELES, Nov. 12, 2026 (GLOBE NEWSWIRE) -- NUGL, Inc. (OTC: NUGL) (“NUGL” or the “Company”), operator of the KAYA cannabis and lifestyle brand in Jamaica, today reported results for the three and nine months ended September 30, 2026. |
| Nov 12, 2026 |
Brazil’s Medical Cannabis Market Reaches $90 Million A Year as Prescriptions Surge
Brazil’s medical cannabis market grew 15% year over year and has more than quadrupled its revenue since August 2022. As prescriptions rise and pharmaceutical competition intensifies, the country is moving toward a new model of domestic production. |
| Nov 11, 2026 |
Canadian licensed cannabis producers in hot water over ‘dumping’ allegations – again
Long accused of “dumping” product into overseas markets to the detriment of foreign competitors, Canadian licensed cannabis producers may at last be punished for the alleged practice. Trade officials in Israel are considering imposing new tariffs on Canadian medical cannabis in response to formal complaints from domestic growers that LPs are violating World Trade Organization rules. |
| Nov 11, 2026 |
Florida Veterans Still Pay Full Price for Medical Marijuana Cards. The House Tried Twice to Fix It. Both Bills Died in the Senate.
On March 4, the Florida House lit its vote board green. HB 887, a bill to cut the medical marijuana ID card fee for honorably discharged veterans from $75 to $15, passed 113 to 0. Its sponsor, Rep. Susan Valdés, described that green board as a way to show veterans how grateful the state is. The bill went to the Senate Rules Committee that same day, was never heard, and died there when the session ended nine days later. |
| Nov 11, 2026 |
Senate Committee Floats Marijuana As Opioid Alternative, Encourages Psychedelic Research And Raises Concerns Over Cannabis-Infused Foods
A key Senate committee is directing federal agencies to consider medical marijuana as an opioid alternative as well as the therapeutic benefits of psychedelics—while also encouraging hemp cultivar and germplasm development and additionally raising concerns about cannabinoid-infused foods. The Senate Appropriations Committee on Tuesday posted the text of two annual funding bills and attached reports that contain the cannabis and drug policy directives. |
| Nov 11, 2026 |
“The Single Convention Has Been One of Our Biggest Nightmares”
Junior “Spirit” Cottle is a political activist and president of the Saint Vincent and the Grenadines Cannabis Revival Committee. Since the 1970s he has led efforts to break with British colonialism and establish greater economic and political ownership and control for Vincentians. For the last four decades he has organized traditional cannabis farmers in Saint Vincent and the Grenadines against US drug eradication exercises, including Operation Weedeater. He is a member of the Caribbean Fairtrade Cannabis Working Group and sits on the Steering Committee of the Global Forum of Producers of Prohibited Plants. |
| Nov 11, 2026 |
Iowa’s Incoming Governor Says Legalizing Marijuana Can Generate ‘Hundreds Of Millions Of Dollars’ For The State
Rob Sand, the Democrat who won Iowa’s gubernatorial election last week, says he plans to move forward with a proposal to legalize marijuana in the state—arguing that it could generate “hundreds of millions of dollars” in annual revenue to fund public schools and other services. “We should treat cannabis the way that we treat alcohol,” the incoming governor said on the latest episode of Iowa Press that aired on Iowa Public Television on Friday. “That’s, year one, a smaller figure—maybe 54 million—but after that, hundreds of millions of dollars.” |
| Nov 11, 2026 |
Lower-Cost Imports Challenge Australian Cannabis Producers
Australia’s medicinal cannabis industry is facing growing pressure from lower-cost imports from Canada and Thailand, raising questions about whether early investments in large cultivation facilities have left domestic producers struggling to compete. |
| Nov 10, 2026 |
Proposition 215, 30 Years Later: When Cannabis in California Was a Movement, Not an Industry
Thirty years after Proposition 215 was passed on November 5, 1996, California cannabis has become a a multibillion-dollar industry. Clinics that look like Apple Stores, lab-tested products, licenses and taxes that the activists of that time could never have imagined. Many of those who enacted the law, however, regret what it took away. Among many growers, patients, and advocates, nostalgia runs deep. The years leading up to legalization in 2016 left them with memories of a close-knit community, direct relationships between growers and consumers, and an industry that could be operated without relying on large corporations or their compliance costs. |
| Nov 10, 2026 |
Cannafest takes place during first year home cannabis cultivation is legal in Czechia
Czechia’s annual trade show for cannabis, Cannafest, took place on the first weekend of November at the PVA exposition center in Let?any, Prague. With none other than the first lady of the Czech Republic, Eva Pavlová, as patron, the exhibition brought together experts from law to medicine, and enthusiasts alike, to enjoy goodies from vendors, live music and public debates regarding cannabis. |
| Nov 10, 2026 |
Curaleaf Secures Required Clearances for Proposed Aurora Cannabis Acquisition
Curaleaf has received all required competition law clearances for its proposed acquisition of Aurora Cannabis. Key Highlights: Germany and Canada were the only jurisdictions requiring competition law clearance for the proposed acquisition. Germany approved the transaction, and Canada’s Competition Bureau issued a no-action letter after completing its review. Curaleaf’s enhanced offer to buy all outstanding Aurora shares remains open until December 4, 2026, unless withdrawn or amended. Curaleaf says the clearances provide greater certainty of completion and support a faster path to closing, subject to remaining offer conditions. Organigram’s competing proposal remains subject to shareholder, court, and regulatory approvals. |
| Nov 10, 2026 |
Proposition 215, 30 Years Later: When Cannabis in California Was a Movement, Not an Industry
Thirty years after Proposition 215 was passed on November 5, 1996, California cannabis has become a a multibillion-dollar industry. Clinics that look like Apple Stores, lab-tested products, licenses and taxes that the activists of that time could never have imagined. Many of those who enacted the law, however, regret what it took away. Among many growers, patients, and advocates, nostalgia runs deep. The years leading up to legalization in 2016 left them with memories of a close-knit community, direct relationships between growers and consumers, and an industry that could be operated without relying on large corporations or their compliance costs. |
| Nov 10, 2026 |
California Legalized Medical Marijuana 30 Years Ago. So Why Is Most of Its Cannabis Still Underground?
Prop 215 made California the first state to legalize medical cannabis 30 years ago this month. Ed Rosenthal, Ethan Nadelmann and Lanny Swerdlow look back on how it won and what it left unfinished. |
| Nov 10, 2026 |
Bills filed to regulate adult-use cannabis in Texas
DALLAS — New bills have been filed to regulate adult-use cannabis in Texas. Under two bills, both filed under the name the Texas Regulation of Cannabis Act, adults 21 and older would be allowed to use, possess, and transport no more than 2 ounces of cannabis, but not more than 15 grams of cannabis concentrate. For personal use, Texans would also be allowed to grow up to 12 cannabis plants on their private residence under the bills. |
| Nov 10, 2026 |
Cannabis Industry Welcomes Excise Stamp Reform in Budget 2026, Continues Call for National Stamp
The Canadian cannabis industry is responding with cautious optimism to recently announced plans to harmonize aspects of the federal cannabis excise stamp and create new enforcement tools. The federal government’s 2026 Budget proposes streamlining the federal excise stamping program by reducing the number of unique cannabis excise duty stamps from 13 to six. It also includes increased financial penalties for those selling cannabis outside of the regulatory system. |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94
